# Abbott Laboratories (ABT) — Q4-2015 Earnings Results

**Report date:** 2016-01-28 (before market open)  
**Sector:** Health Care / Health Care Equipment  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/ABT/earnings/Q4-2015

## Post-Earnings Brief

### Headline

Abbott Laboratories Beats on EPS, Stock Down 9.3%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.62 | N/A | +1.31% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Unknown

No transcript is on record, and the analysis is based solely on numerical results.

### Guidance Changes

No forward guidance data is available.

### What It Means

Abbott Laboratories reported an EPS of $0.62, slightly beating expectations. However, the stock fell by 9.3%, indicating investor concerns despite the earnings beat. The lack of revenue data and management commentary may have contributed to the negative stock reaction.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/ABT/earnings/Q4-2015_